|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net income (loss) | |||||
| Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: | |||||
| Depreciation of property, plant and equipment | |||||
| Amortization of intangible assets | |||||
| Depreciation and amortization | |||||
| Provision to write down inventories to net realizable value | |||||
| Impairment of asset held-for-sale | |||||
| Loss on impairment and disposal of property, plant and equipment | |||||
| Stock-based compensation expenses | |||||
| Loss from business disposition | |||||
| Impairment of goodwill and intangible assets | |||||
| Impairment of privately-held companies | |||||
| Deferred income taxes, net | |||||
| Loss from sale of business | |||||
| Gain from repurchasing of convertible notes | |||||
| Loss (gain) from exchange rate fluctuations | |||||
| Loss (gain) from sale of property, plant and equipment | |||||
| Cumulative translation adjustment, including intra-entity transactions that are of a long-term investment reclassified from other comprehensive income (loss) | |||||
| Other items | |||||
| Changes in assets and liabilities: | |||||
| Trade receivables, net | |||||
| Inventories, net | |||||
| Prepaid expenses and other assets | |||||
| Operating lease right-of-use assets, net | |||||
| Trade payables | |||||
| Employees and payroll accruals | |||||
| Warranty obligations | |||||
| Deferred revenues and customers advances | |||||
| Operating lease liabilities | |||||
| Accrued expenses and other liabilities | |||||
| Net cash provided by (used in) operating activities | |||||
| Cash flows from investing activities: | |||||
| Investment in available-for-sale marketable securities | |||||
| Proceeds from maturities of available-for-sale marketable securities | |||||
| Proceeds from sales of available-for-sale marketable securities | |||||
| Purchase of property, plant and equipment | |||||
| Proceeds from sale of investment in privately-held company | |||||
| Business dispositions, net of cash sold | |||||
| Business combinations, net of cash acquired | |||||
| Proceeds from sale of property, plant and equipment | |||||
| Advance related to held-for-sale asset | |||||
| Purchase of intangible assets | |||||
| Disbursements for loans receivables | |||||
| Investment in privately-held companies | |||||
| Proceeds from sale of a privately-held company | |||||
| Withdrawal from bank deposits, net | |||||
| Proceeds from loans receivables | |||||
| Proceeds from governmental grant | |||||
| Repayment related to governmental grant | |||||
| Other investing activities | |||||
| Net cash provided by (used in) investing activities | |||||
| Cash flows from financing activities: | |||||
| Repurchase of common stock | |||||
| Repurchase of convertible debt | |||||
| Proceeds from issuance of Notes 2029, net of issuance costs | |||||
| Capped call transactions related to Notes 2029 | |||||
| Repayment of convertible notes at maturity | |||||
| Tax withholding in connection with stock-based awards, net | |||||
| Payments of finance lease liability | |||||
| Proceeds from secondary public offering, net of issuance costs | |||||
| Repayment of bank loans | |||||
| Other financing activities | |||||
| Net cash used in financing activities | |||||
| Increase (decrease) in cash and cash equivalents | |||||
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | |||||
| Increase (decrease) in cash, cash equivalents and restricted cash including cash classified within current held-for-sale assets | |||||
| Less: change in cash classified within current held-for-sale assets | |||||
| Increase (decrease) in cash, cash equivalents, and restricted cash | |||||
| Cash, cash equivalents and restricted cash, beginning of period | |||||
| Cash, cash equivalents and restricted cash, end of period | |||||
| Supplemental disclosure of non-cash activities: | |||||
| Purchase of intangible assets and business combinations | |||||
| Issuance of Common stock under employee stock purchase plan | |||||
| Right-of-use asset recognized with corresponding lease liability including changes in lease liabilities from lease modifications and terminations | |||||
| Purchase of property, plant and equipment | |||||
| Supplemental disclosure of cash flow information: | |||||
| Cash paid for income taxes,net | |||||
| Cash paid for interest on convertible debt and bank loans | |||||
Loading...